Indian President backs affordable drugs

23 February 2009

The Indian government is committed to increasing spending on its infrastructure, including that related to overall health care, and is  also determined to keep a check on the prices of medicines, the nation's  President, Pratibha Devisingh Patil, has told Parliament. The total will  rise to 9% of Gross Domestic Product, with some 140.0 billion rupees  ($2.99 billion) going to investment to revive some public sector  companies, she said.

Speaking to a joint session of parliamentarians earlier this month,  President Patil noted that drugs and pharmaceuticals play an important  role in India's health care.

Manufacturing undertakings

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight